**Core Concept**
CD-95, also known as Fas receptor, is a death receptor that plays a crucial role in initiating apoptosis (programmed cell death). This receptor is a member of the tumor necrosis factor receptor (TNFR) superfamily and is expressed on the surface of various cells, including lymphocytes and hepatocytes. Engagement of CD-95 by its ligand, FasL, triggers a cascade of intracellular signaling events leading to apoptosis.

**Why the Correct Answer is Right**
The correct answer involves the CD-95/Fas pathway, which is a key mechanism of apoptosis induction. When FasL binds to CD-95, it activates caspase-8, a cysteine protease that cleaves and activates downstream caspases, ultimately leading to the execution phase of apoptosis. This pathway is essential for maintaining immune homeostasis and eliminating self-reactive lymphocytes. The CD-95/Fas pathway is also involved in various physiological and pathological processes, including autoimmune diseases and cancer.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is likely a distractor and does not directly relate to the CD-95/Fas pathway. While other death receptors, such as TNFR1, can also initiate apoptosis, they are not directly associated with CD-95.
**Option B:** This option may refer to the mitochondrial pathway of apoptosis, which involves the release of cytochrome c and activation of caspase-9. While this pathway is also important for apoptosis, it is not directly related to CD-95.
**Option C:** This option is unclear and may be a distractor. Without more context, it is difficult to determine what this option is referring to.
**Option D:** This option is a distractor and does not directly relate to the CD-95/Fas pathway. While other signaling pathways, such as the PI3K/Akt pathway, can regulate apoptosis, they are not directly associated with CD-95.

**Clinical Pearl / High-Yield Fact**
The CD-95/Fas pathway is a key mechanism of apoptosis induction, and dysregulation of this pathway has been implicated in various diseases, including autoimmune disorders and cancer. Understanding the CD-95/Fas pathway is essential for developing targeted therapies for these conditions.

**Correct Answer:** .